Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion type Assertion NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_head.
- NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion description "[Moreover, hypermethylation analysis of E-cadherin, p14 or RASSF1A genes in urine sediment DNA detected in 85% (22/26) of superficial, 85% (11/13) of low grade, 75% (15/20) of invasive and 79% (26/33) of high grade bladder cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_provenance.
- NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion evidence source_evidence_literature NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_provenance.
- NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion SIO_000772 19181545 NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_provenance.
- NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion wasDerivedFrom befree-20150227 NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_provenance.
- NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_assertion wasGeneratedBy ECO_0000203 NP304232.RAXeEHnDnZUKJRARNqmky7z4_1Bf1JvOXd_YRvVkg2Z7Q130_provenance.